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Abstract: A library of monoterpene-based aminodiols was 
synthesized and applied as chiral catalysts in the addition of 
diethylzinc to benzaldehyde. The reduction of a bicyclic α-methylene 
ketone, derived from natural (-)-limonene followed by epoxidation, 
gave the key intermediate epoxy alcohol. Ring opening of the oxirane 
ring with primary amines induced by lithium perchlorate afforded the 
required aminodiols. The substituent-dependent ring closures of 
secondary aminodiols with formaldehyde resulted in both 
spirooxazolidines and a fused 1,3-oxazine. Cyclisation reactions of 
the studied aminodiols, resulting in spirocyclic oxazolidines and an 
isomeric perhydro-1,3-oxazine-fused compound along with the 
possible iminium intermediates, were analyzed by a systematic series 
of comparative DFT modelling carried out at B3LYP/6-31+G(d,p) level 
of theory. 
Introduction 
Chiral synthons that can be applied successfully in 
asymmetric homogenous and heterogeneous catalysis are of 
increasing importance in organic chemistry.[1–3] A large number of 
natural products such as α- and β-pinene,[4–6] 2- and 3-carene[7,8] 
and (+)-pulegole[9,10] serve as important starting materials for the 
synthesis of bi- and trifunctional chiral compounds and 
heterocycles. Monoterpene-based 1,2- and 1,3-amino alcohols 
have been demonstrated to be excellent chiral auxiliaries in a 
wide range of stereoselective transformations including 
intramolecular radical cyclisations,[11]  intramolecular [2+2] 
photocycloaddition[12] and Grinard addition.[13,14] 
Furthermore, aminodiols, combining the chemical 
properties of 1,2- and 1,3-amino alcohols derived from naturally 
occurring terpenes, are excellent starting materials and catalysts 
of stereoselective synthesis.[15–20] Moreover, aminodiols are 
excellent building blocks for the synthesis of 1,3-oxazines and 
oxazolidines. Depending upon the hydroxy group involved in ring 
closure with the amino group, five- to six-membered rings may be 
formed stereoselectively. The resulting bicyclic heterocycles 
bearing a free hydroxy group can contribute to high 
enantioselective inductions in asymmetric addition reactions.[21–24] 
Besides their chemical interest, some natural 
aminodiols exhibit marked biological activity. For example, 
aristeromycin, first isolated from Streptomyces citricolor and its 
modified derivatives belong to an important group of carbocyclic 
nucleosides that exhibit a wide range of pharmacological 
properties such as antiviral, anticancer and antitoxoplasma 
activities. Aristeromycin analogues, in particular, are widely used 
as antiviral agents against a range of viruses, including human 
immunodeficiency, hepatitis B, herpes simplex, varicella-zoster, 
influenza and hepatitis C virus.[25–27] Other aminodiols may serve 
as starting materials for the synthesis of biologically active natural 
compounds. For example, cytoxazone a microbial metabolite 
isolated from Streptomyces species is a selective modulator of 
secretion of TH2 cytokine.[26,27] 
In the present contribution we report the stereoselective 
synthesis of new bicyclic 3-amino-1,2-diols as potential building 
blocks and chiral auxiliaries starting from  commercially  available 
natural  (-)-limonene. In addition, we have studied the substituent-
dependent ring closure of these aminodiols with formaldehyde. 
Competitive ring closure processes can provide both 
spirooxazolidine ring systems and condensed 1,3-oxazines. The 
results of experimental and theoretical study of these synthons 
may expand our knowledge of this type of trifunctional building 
blocks in the design/construction of 3D small molecules. 
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Results and Discussion 
Chiral bicyclic aminodiols were prepared from 
commercially available (-)-limonene 1 starting with regioselective 
hydroxylation to afford allylic alcohol 2.[28–30] The resulting allylic 
alcohol was oxidized to aldehyde 3,[28] which was then converted 
to carboxylic acid 4 applying a literature method.[31–34] 
Intramolecular acylation of isoperillic acid 4 performed using 
earlier methods[34,35] resulted in bicyclic methylene ketone 5 as a 
single product (Figure 1). 
 
Figure 1. Synthesis of bicyclic methylene ketone 5 
Stereoselective reduction of 5 gave allylic alcohol 6 
according to a literature procedure applied for similar 
monoterpenic -methylene ketones.[10] Epoxidation of 6 in dry 
toluene in the presence of vanadyl acetylacetonate as catalyst 
gave a mixture of 7 and 8. Note that 8 exists as a 4:1 mixture of 
two diastereomers (Scheme 1).[36–38] In addition, it is interesting 
that the ratio of 7 and 8 depends on the temperature. 
 
Scheme 1. (i) NaBH4, MeOH, 0 °C, 4 h, 67%; (ii) 70% t-BuOOH, VO(acac)2, 
dry toluene, 25 °C, 12 h, 60% (optimised combined yield of 7 and 8). 
While at 25 °C 7 was formed as the main product, the 
ratio of the two products was found to be 1:1 at 100 °C. At lower 
temperature, the yield dropped dramatically despite the elongated 
reaction time without any significant change in the 7 to 8 ratio 
(Table 1). The yield of 7 could not be increased by either changing 
the ratio of 6 and the oxidation reagent or the temperature (Table 
1). 
The separation of epoxide 7 and 8 could not be 
effectively performed without decomposition of the products. 
Since our earlier results clearly demonstrated that 
substituents at nitrogen of aminodiols definitely influenced the 
efficiency of their catalytic activity,[4,39] aminodiol library 9-12 was 
prepared by aminolysis of epoxide 7 with primary amines and 
lithium perchlorate as catalyst (Scheme 2).[7,17,39,40] 
   
Table 1. Epoxidation reaction of 6   
Entry 
6  
(mol) 
t-BuOOH 
(mol) 
T 
 [°C] 
t 
 [h] 
Ratio 
[7:8] [a] 
Yield 
[%][b] 
1 1 1.5 0 > 96 4:1 40 
2 1 1.5 25 12 3:1 60 
3 1 1.5 100 4 1:1 70 
4 1 3.0 0 48 1:1 60 
5 1 3.0 25 6 1:1 65 
[a] Based on 1H-NMR measurements of the crude product. [b] Isolated, 
combined yield of 7 and 8. 
 
When tert-butylamine was applied, the opening of the 
oxirane ring failed, which clearly shows that from the point of view 
of steric hindrance, the isopropyl group represents the upper limit 
of the N-substituent. Accordingly, our efforts in the opening of 
epoxide with secondary amines was also unsuccessful.[41] 
Interestingly, during aminolysis with primary amines under the 
applied conditions, epoxide 7 was transformed preferentially while 
8 did not react. This is probably due to steric hindrance exerted 
by the methyl group of 8 at the  position. Therefore, aminodiols 
9-12 could be easily separated from 8 on a gram scale by simple 
column chromatography with good yields. 
 
Scheme 2. (i) RNH2, LiClO4, MeCN, 70-80 °C, 4 h, 50-67% 
The relative configurations of compounds 9-12 were 
determined by means of NOESY experiments: clear NOE signals 
were observed between the H-1 and H-9, H-9 and H-6, H-6 and 
H-5, H-8 as well as OH-6 and OH-7 protons (Figure 2). 
Debenzylation via hydrogenolysis of compounds 9-11 over Pd/C 
in MeOH resulted in primary aminodiol 13 in moderate yield 
(Scheme 3). 
Since the ring closure of monoterpene-based 
aminodiols with rigid structures enhances their catalytic 
potential,[7,8] we incorporated one of the hydroxy groups of 
compounds 9-12 into a condensed 1,3-oxazine or 
spirooxazolidine ring.[42–44] When aminodiols 9-11 were reacted 
with formaldehyde at room temperature, spirooxazolidines 14-16 
were obtained in a highly regioselective ring closure. In contrast, 
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aminodiol 12 yielded a mixture of spirooxazolidine 17 and 1,3-
oxazine 18.[45] 
 
Figure 2. Determination of the aminodiol structures by NOESY 
The temperature strongly affected the ratio of the two 
products. At low temperature (0 °C), exclusive formation of 
compound 17 was observed, while 17 and 18 were formed in a 
ratio of 2:1 at 25 °C. At higher temperature, no significant changes 
in the 17/18 ratio could be achieved (Scheme 3). Applying p-
toluenesulfonic acid (TsOH) as additive to decrease the pH to 1-
2, the ratio of 17 and 18 did not change significantly (17:18 = 
1.7:1) and, at the same time, the product yield dropped to 40%. 
 
Scheme 3. from 9-11, 5% Pd/C, MeOH, H2, 1 atm, 25 °C, 20 h, 70%, (ii) R = 
35% HCHO sol., Et2O, 0 °C, 1 h, 60-70% 
In order to get insight into the experienced substrate 
dependence of the acid-catalyzed, formaldehyde-mediated 
cyclisation reactions of the studied aminodiols, all resulting 
spirocyclic oxazolidines and isomeric perhydro-1,3-oxazine-fused 
compound 18 along with the possible iminium intermediates 
(Schemes 4 and 5) were analyzed by a systematic series of 
comparative DFT modelling carried out at B3LYP/6-31+G(d,p) 
level of theory.[46,47] 
Each optimized structure, representing global or local 
minimum on the potential energy surfaces, features a 
characteristic intramolecular hydrogen-bond network involving 
the skeletal OH groups. Of note that in the optimized structures of 
iminium intermediate types 22-24 the proximal C=C double bond 
in the seven-membered ring is also involved in these 
systematically assembled H-bonding networks as a -donor 
component. 
The calculated relative energetics of the optimized 
structures of spirocyclic products and their oxazine-fused 
counterparts [E(spiro→oxazine, spiro*→oxazine*)=11.8-13.8 
kcal/mol: Schemes 4 and 5] are obviously in line with the 
experimental findings disclosing highly preferential formation of 
the spirocyclic isomers. Moreover, according to Boltzmann 
equation, the aforementioned large differences would principally 
allow the formation of fused oxazines in hardly detectable traces. 
However, under the acidic conditions employed for cyclisation, 
the relative stability of relevant pairs of iminium intermediates 22/I-
24/I and 22/II-24/II with slightly different relative stability (0.2-1.9 
kcal/mol), preformed for alternative modes of ring closure, might 
also be of crucial importance. It must be emphasized that even 
these small values are also in correlation with the preferred 
formation of the spirocyclic products. Nevertheless, they allow the 
formation of fused oxazines in experimentally detectable 
concentrations. On the other hand, the amount of iminium cations 
relative to the appropriate neutral spirooxazolidine or 1,3-oxazine 
components in the reaction mixtures is highly dependent on the 
acidity of the reaction mixture. This was spectacularly indicated 
by the dramatic differences (even with opposite signs) in the 
calculated relative energetics characterizing two selected types of 
reversible cyclisation reactions 14-17+H3O+↔22+-25++H2O and 
14-17+H9O4+↔22+-25++4H2O [+(52.0-80.7) kcal/mol and –(2.2-
30.9) kcal/mol, respectively: Schemes 4 and 5]. Consequently, it 
can be assumed that under appropriate acidic conditions the 
aforementioned relative population of iminium cations 22+-24+/I, 
22+-24+/II, 25+/I, 25+/II, and 25+/III might indirectly control the 
detectable relative amounts of the spirocyclic oxazolidines and 
fused 1,3-oxazines. Note that their interconversion under neutral 
conditions is prevented or significantly slowed down by high 
activation barriers (24.7-42.7 kcal/mol: Schemes 4 and 5).  
Consequently, it can be assumed that under appropriate 
acidic conditions the aforementioned relative population of 
iminium cations 22+-24+/I, 22+-24+/II, 25+/I, 25+/II, and 25+/III might 
indirectly control the detectable relative amounts of the spirocyclic 
oxazolidines and fused 1,3-oxazines. Note that their 
interconversion under neutral conditions is prevented or 
significantly slowed down by high activation barriers (24.7-42.7 
kcal/mol: Schemes 4 and 5). 
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Scheme 4. Pathways, energetics and activation barriers (kcal/mol) calculated for the interconversion of 14-16, 19-21 and the relevant iminium cationic intermediates 
involving the inversions of the nitrogen stereogenic centre present in the neutral molecules. 
 
The slightly enhanced tendency of isopropyl-substituted 
model 12 to afford fused oxazine product 18 might be due to acid-
catalyzed formation of iminium cation 25+/II, the unique 
intermediate that is preformed to alternative modes of cyclisation, 
in concentration comparable to those of its rotamers 25+/I and 
25+/III preformed to single modes of ring closure (Scheme 5). The 
assumed modes of ring closure of iminium cations are in accord 
with the partial bonding interactions involving the appropriate 
hydroxy groups and the carbenium centre as disclosed by the 
analysis of their bonding MO’s (Figure 3). Partial C---O 
interactions involving the tertiary hydroxy group were disclosed in 
cations 22+/I and 25+/I (cf. HOMO-5 and HOMO-9, respectively), 
while similar interactions between the cationic centre and the 
secondary hydroxy group are represented by HOMO-14 and 
HOMO-10 in cations 22+/II and 25+/III, respectively. On the other 
hand, it is of pronounced interest that in cation 25+/II a three-
centred interaction of the carbenium centre with both hydroxy 
groups spectacularly visualized by HOMO-15 gives plausible 
support to the view about the abovementioned alternative 
directions of cyclisation of this intermediate. 
All calculations were carried out by using Gaussian 09 
program packege.[48] Upon request, the optimized structures are 
provided by the authors. 
Transition states were localized on the potential energy 
surfaces by QST2 method[49] at B3LYP level of theory using 6-
31+G(d,p) basis set. 
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 Scheme 5. Pathways, energetics and activation barriers (kcal/mol) calculated for the interconversion of 17,18 and the relevant iminium cationic intermediates 
involving the inversions of the nitrogen stereogenic centre present in the neutral molecules.
The aminodiol derivatives (9-18) were applied as chiral 
catalysts in the enantioselective addition of diethylzinc to 
benzaldehyde (26) to form (S)- and (R)-1-phenyl-1-propanol 27 
(Scheme 6). 
 
Scheme 6. Model reaction for enantioselective catalysis. 
 
The results are presented in Table 2. The enantiomeric 
purity of 1-phenyl-1-propanols (S)-27 and (R)-27 was determined 
by GC on a CHIRASIL-DEX CB column using literature 
methods.[7,8,50,51] Low to good enantioselectives were observed. 
Aminodiol 12 afforded the best ee value (ee = 55%) with an (R)-
selectivity (entry 4), while a 2:1 mixture of 17/18 showed the best 
ee value (ee = 80%) with an (S)-selectivity (entry 10). The results 
obtained clearly show that the spirooxazolidine ring has poorer 
catalytic performance compared with the 1,3-oxazine ring system. 
These results are in good correlation with those observed with 
pinane- or sabinane-based spirooxazolidines and carane-fused 
1,3-oxazines in our earlier studies.[44,52,53] 
 
Table 2. Addition of diethylzinc to benzaldehyde, catalyzed by aminodiols, 
oxazolidines and 1,3-oxazines 
Entry Liganda Yieldb (%) eec (%) Configurationd 
1 9 80 16 (R) 
2 10 85 24 (R) 
3 11 87 40 (R) 
4 12 89 55 (R) 
5 13 87 35 (R) 
6 14 85 30 (R) 
7 15 88 6 (R) 
8 16 83 0 - 
9 17 90 6 (R) 
10 17/18 (2:1) 87 80 (S) 
[a] 10 mol%. [b] After silica column chromatography. [c] Determined on the crude 
product by GC (Chirasil-DEX CB column). [d] Determined by comparing the tR of 
GC analysis and optical rotations with the literature date. 
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Figure 3. Selected MO’s of the iminium intermediates that highlight the alternative modes of partial bonding between the nucleophilic tertiary or secondary 
carbinol unit and the electrophilic carbenium centre (in 22+/I, 22+/II, 25+/I and 25+/III) and the latter’s simultaneous three-centred interaction with both hydroxy 
groups (in 25+/II)
Conclusions 
Starting from natural (-)-limonene, a limonene-based 
aminodiol library was created whereas the reaction of aminodiols 
with formaldehyde resulted in bicyclic monoterpene-fused 
spirooxazolidines in N-substituent dependent ring closures. The 
regioselective nature of the ring closure proved to be N-
substituent-dependent, and molecular modelling was applied to 
explain this phenomenone. The aminodiols and their ring-closed 
derivatives were applied as chiral catalysts in the enantioselective 
addition of diethylzinc to benzaldehyde. The 1,3-oxazine obtained 
proved to be a good catalyst in the addition of diethylzinc to 
benzaldehyde. 
Experimental Section 
General Methods: 1H- and 13C- NMR spectra were recorded on 
a Bruker Avance DRX 400 [400 and 100 MHz, respectively,  = 0 
ppm (TMS)] and Bruker Avance DRX 500 [500 and 125 MHz, 
respectively,  = 0 ppm (TMS)]. Chemical shifts () are expressed 
in ppm relative to TMS as internal reference. J values are given 
in Hz. Microanalyses were performed on a Perkin–Elmer 2400 
elemental analyser. GC measurements were made on Perkin-
Elmer Autosystem KL GC consisting of a Flame Ionisation 
Detector and a Turbochrom Workstation data system (Perkin-
Elmer Corpotation Norwalk, USA). The separation of O-acetyl 
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derivatives of enantiomers was carried out on a CHIRASIL-DEX 
CB column (2500 × 0.265 mm I.D). 
Optical rotations were determined with a Perkin–Elmer 341 
polarimeter. Melting points were determined on a Kofler 
apparatus and are uncorrected. Chromatographic separations 
were carried out on Merck Kieselgel 60 (230–400 mesh ASTM). 
Reactions were monitored with Merck Kieselgel 60 F254-
precoated TLC plates (0.25 mm thickness). 
Starting materials: (S)-Limonene 1 is available commercially 
from Merck Co. All chemicals and solvents were used as supplied. 
THF and toluene were dried over Na wire. (S)-Isoperillyl alcohol 
(2), (S)-p-mentha-1,8-dien-9-al (3), (S)-p-mentha-1,8-dien-9-oic 
acid (4) and (1S,5S)-4-methyl-7-methylenebicyclo[3.2.1]oct-3-en-
6-one (5) were prepared according to literature procedures, and 
all spectroscopic data were similar as described therein.[28],[34] 
(1S,5S,6R)-4-Methyl-7-methylenebicyclo[3.2.1]oct-3-en-6-ol (6): 
A suspension of NaBH4 (1.5 g, 39.65 mmol) in MeOH (21 mL) was 
added dropwise to an ice-cooled solution of 5 (1.5 g, 10.12 mmol) 
in MeOH (18 mL). Stirring was continued for 4 h at 0 °C. When 
the reaction was complete, the mixture was poured into brine and 
the product was extracted with diethyl ether (3 × 100 mL). The 
combined extracts were washed with water and dried over 
anhydrous Na2SO4. The solvent was evaporated in vacuo and the 
crude product was used for the next step without further 
purification. 
Compound 6: 1.02 g (67%); white crystals; mp: 50-53 °C; [α]D20 = 
-188 (c 0.20, MeOH). 1H NMR (400 MHz, CDCl3)  (ppm): 1.64-
1.70 (m, 3H), 1.76 (s, 3H), 1.93 (d, J = 16.8 Hz, 1H), 2.39-2.47 (m, 
2H), 2.80 (s, 1H), 4.58 (s, 1H), 5.14 (s, 1H), 5.19 (s, 1H), 5.32 (s, 
1H). 13C NMR (100 MHz, CDCl3)  (ppm): 25.0 (CH3), 30.6 (CH2), 
38.5 (CH2), 38.9 (CH), 44.4 (CH), 81.3 (CH), 108.6 (CH2), 120.1 
(CH), 137.7 (Cq), 160.0 (Cq). Anal. Calcd for C10H14O: C,79.96; H, 
9.39. Found: C, 79.93, H, 9.40. 
(1S,2'R,5S,7R)-2-Methylspiro[bicyclo[3.2.1]oct[2]ene-6,2'-
oxiran]-7-ol (7) and (1R,6R,8R)-2-methyl-7-methylene-3-
oxatricyclo[4.2.1.02,4]nonan-8-ol (8): To a stirred pale red 
solution of 6 (1.0 g, 6.56 mmol) and vanadyl acetylacetonate (7 
mg) in dry toluene (30 mL), briefly (Na2CO3) dried t-BuOOH (70% 
solution in H2O, 1.30 g, 10.1 mmol) in dry toluene (30 mL) was 
added dropwise at 25 °C. The red colour of the solution darkened 
during the addition then faded to brownish yellow. Stirring was 
continued (20 h), whereupon potassium hydroxide (0.55 g, 9.8 
mmol) in brine (25 mL) was added. The mixture was extracted 
with toluene (3 × 100 mL) and the organic layer was washed with 
brine before drying (Na2SO4) and evaporation. Flash column 
chromatography (n-hexane:ethyl acetate 4:1) gave the mixture of 
epoxides 7 and 8 as a pale yellow oil. 
Mixture of compound 7 and 8: 0.66 g (60%); colourless oil. 1H 
NMR (400 MHz, CDCl3)  (ppm): 1.36-1.42 (5H, m, minor), 1.51-
1.54 (m, minor, 1H), 1.70-1.77 (m, 5H, minor overlapped with 
major), 2.11-2.18 (m, 5H, minor overlapped with major), 2.42-2.44 
(m, 1H, minor overlapped with major), 2.61 (br s, 1H, minor), 2.81 
(d, J = 5.2 Hz, 1H, major), 2.92 (d, J = 2.6 Hz, 1H, minor), 2.96 (d, 
J = 5.2 Hz, 1H, major), 3.16 (d, J = 11.9 Hz, 1H, minor), 4.12-4.16 
(m, 1H, major), 4.29-4.34 (m, 1H, minor), 4.95 (d, J = 2.2 Hz, 1H, 
minor), 5.10 (s, 1H, minor), 5.33 (d, J = 1.3 Hz, 1H, major). 13C 
NMR (100 MHz, CDCl3)  (ppm): 24.4 (CH3, minor), 24.7 (CH3, 
major), 28.8 (CH2, major), 30.0 (CH2, major), 35.3 (CH, major), 
36.6 (CH2, minor), 36.7 (CH, minor), 42.7 (CH, minor), 44.1 (CH, 
major), 51.6 (CH2, major), 56.8 (CH, minor), 64.8 (Cq, major), 75.9 
(CH, major), 77.4 (CH, minor), 106.3 (CH2, minor), 119.7 (CH, 
major), 137.3 (Cq, major), 157.4 (Cq, minor). Anal. Calcd for 
C10H14O2: C, 72.26; H, 8.49. Found: C, 72.30; H, 8.50. 
Isolated compound 8: 0.16 g (15%); colourless oil. 1H NMR (400 
MHz, CDCl3)  (ppm): 1.26-1.30 (m, 3H, minor), 1.36-1.42 (m, 5H, 
major), 1.50-1.55 (m, 1H, major), 1.70-1.80 (m, 2H, minor), 1.96-
1.98 (m, 1H, minor), 2.10-2.18 (m, 3H, minor overlapped with 
major), 2.41-2.43 (m, 1H, minor overlapped with major), 2.61 (br 
s, 1H, major), 2.86 (d, J = 3.5 Hz, 1H, minor), 2.92 (d, J = 2.5 Hz, 
1H, major), 3.16 (d, J = 11.9 Hz, 1H, major), 3.55 (d, J = 12.5 Hz, 
1H, minor), 4.17-4.25 (m, 1H, minor), 4.29-4.34 (m, 1H, major), 
4.95 (d, J = 2.1 Hz, 1H, major), 5.10 (s, 1H, major). 13C NMR (100 
MHz, CDCl3)  (ppm): 24.6 (CH3, major), 30.2 (CH2, major), 36.8 
(CH2, major), 36.9 (CH, major), 42.9 (CH, major), 57.0 (CH, major), 
77.6 (CH, major), 106.5 (CH2, major). (Anal. Calcd for C10H14O2: 
C, 72.26; H, 8.49. Found: C, 72.30; H, 8.50. 
General methods for epoxide ring opening with primary 
amines: To a solution of the mixture of epoxide 7 and 8 (0.66 g, 
3.97 mmol) in MeCN (50 mL) was added a solution of the 
appropriate amine (7.94 mmol) in MeCN (15 mL) and LiClO4 (0.07 
g, 0.66 mmol). The mixture was kept at reflux temperature for 4 
hours. When the reaction was completed (indicated by TLC), the 
mixture was evaporated to dryness, and the residue was 
dissolved in water (15 mL) and extracted with CH2Cl2 (3 × 20 mL). 
The combined organic phase was dried (Na2SO4), filtered and 
concentrated. The crude product was purified by column 
chromatography on silica gel with an appropriate solvent mixture 
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(CHCl3:MeOH 19:1). The crude products after purification were 
recrystallized in diethyl ether resulting in compounds 9-12. 
(1S,5S,6R,7R)-6-((Benzylamino)methyl)-2-
methylbicyclo[3.2.1]oct-2-ene-6,7-diol (9): 0.54 g (50%); white 
crystals; mp: 190-200 °C; [α]D20 = -62 (c 0.24, MeOH). 1H NMR 
(400 MHz, DMSO-d6)  (ppm):1.45 (m, 2H), 1.61 (s, 3H), 1.97 (d, 
J = 17.2 Hz, 1H), 2.17-2.24 (m, 3H), 2.73 (d, J = 12.5 Hz, 1H), 
2.81 (d, J = 12.5 Hz, 1H), 3.84 (t, J = 5.5 Hz, 1H), 4.01 (br s, 1H), 
4.12 (s, 2H), 5.11 (s, 1H), 5.65 (d, J = 5.5 Hz, 1H), 7.38-7.60 (m, 
5H), 8.97 (br s, 1H). 13C NMR (100 MHz, DMSO-d6)  (ppm): 24.8 
(CH3), 27.9 (CH2), 28.2 (CH2), 39.9 (CH), 43.3 (CH), 50.6 (CH2), 
54.5 (CH2), 74.8 (Cq), 76.9 (CH), 118.8 (CH), 128.5 (CH Ar), 128.8 
(CH Ar), 130.4 (CH Ar), 131.8 (Cq Ar), 137.2 (Cq). Anal. Calcd for 
C17H23NO2: C, 74.69; H, 8.48; N, 5.12. Found: C, 74.73; H, 8.45; 
N, 5.08. 
(1S,5S,6R,7R)-2-Methyl-6-((((S)-1-
phenylethyl)amino)methyl)bicyclo[3.2.1]oct-2-ene-6,7-diol (10): 
0.68 g (60%); white crystals; mp: 190-195 °C; [α]D20 = -87 (c 0.21, 
MeOH). 1H NMR (400 MHz, DMSO-d6)  (ppm): 1.39-1.43 (m, 2H), 
1.60 (s, 3H), 1.65 (d, J = 6.7 Hz, 1H), 1.90-1.99 (m, 2H), 2.17-2.23 
(m, 2H), 2.46 (d, J = 12.4 Hz, 1H), 2.78 (d, J = 12.4 Hz, 1H), 3.95 
(s, 1H), 3.99 (br s, 1H), 4.31 (m, 1H), 5.10 (s, 1H), 5.67 (br s, 1H), 
7.35-7.60 (m, 5H), 8.84 (br s, 1H). 13C NMR (100 MHz, DMSO-d6) 
 (ppm) 19.9 (CH3), 24.7 (CH3), 27.9 (CH2), 28.1 (CH2), 40.3 (CH), 
43.4 (CH), 54.5 (CH2), 58.4 (CH), 74.8 (Cq), 76.6 (CH), 118.7 (CH), 
127.9 (CH Ar), 128.5 (CH Ar), 128.7 (CH Ar), 137.2 (Cq). Anal. 
Calcd for C18H25NO2: C, 75.22; H, 8.77; N, 4.87. Found: C, 75.28; 
H, 8.65; N, 4.89. 
(1S,5S,6R,7R)-2-Methyl-6-((((R)-1-
phenylethyl)amino)methyl)bicyclo[3.2.1]oct-2-ene-6,7-diol (11): 
0.74 g (65%); white crystals; mp: 215-220 °C; [α]D20 = -65 (c 0.20, 
MeOH). 1H NMR (400 MHz, DMSO-d6)  (ppm): 1.24-1.33 (m, 2H), 
1.59 (s, 3H), 1.64 (d, J = 6.1 Hz, 3H), 1.96 (d, J = 18.2 Hz, 1H), 
2.15-2.25 (m, 3H), 2.37 (d, J = 12.5 Hz, 1H), 2.81 (d, J = 12.3 Hz, 
1H), 3.68 (t, J = 5.40 Hz, 1H), 3.98 (s, 1H), 4.27 (br s, 1H), 5.10 
(s, 1H), 5.67 (br s, 1H), 7.36-7.63 (m, 5H), 8.97 (br s, 1H). 13C 
NMR (100 MHz, DMSO-d6)  (ppm) 24.7 (CH3), 28.0 (CH2), 28.1 
(CH2), 43.3  (CH), 54.2 (CH2), 58.3 (CH), 74.8 (Cq), 76.9 (CH), 
118.7 (CH), 127.8 (CH Ar), 128.5 (CH Ar), 128.7 (CH Ar), 137.2 
(Cq). Anal. Calcd for C18H25NO2: C, 75.22; H, 8.77; N, 4.87. 
Found: C, 75.30; H, 8.57; N, 4.90. 
(1S,5S,6R,7R)-6-((Isopropylamino)methyl)-2-
methylbicyclo[3.2.1]oct-2-ene-6,7-diol (12): 0.60 g (67%); white 
crystals; mp: 195-200 °C; [α]D20 = -64 (c 0.28, MeOH). 1H NMR 
(500 MHz, DMSO-d6)  (ppm): 1.24 (d, J = 6.2 Hz, 6H), 1.50 (d, J 
= 11.7 Hz, 1H), 1.56-1.58 (m, 1H), 1.63 (s, 3H), 2.02 (d, J = 16.8 
Hz, 1H), 2.20-2.26 (m, 3H), 2.75 (d, J = 12.4 Hz, 1H), 2.93 (d, J = 
12.5 Hz, 1H), 3.28-3.30 (m, 1H), 3.77 (t, J = 5.4 Hz, 1H), 4.05 (s, 
1H), 5.15 (br s, 1H), 5.52 (d, J = 5.6 Hz, 1H), 8.01 (br s, 2H). 13C 
NMR (125 MHz, DMSO-d6)  (ppm): 18.30 (CH3), 24.8 (CH3), 27.8 
(CH2), 28.2 (CH2), 39.3 (CH), 43.3 (CH), 50.4 (CH), 52.3 (CH2), 
74.7 (Cq), 77.3 (CH), 119.0 (CH), 137.1 (Cq). Anal. Calcd for 
C13H23NO2: C, 69.29; H, 10.29; N, 6.22. Found: C, 69.30; H, 
10.25; N, 6.25. 
General procedure for the ring closure of compound 9-12 
with formaldehyde  
Method A: To a solution of aminodiol 9-12 (1.8 mmol) in 5 mL 
diethyl ether was added 20 mL of aqueous formaldehyde (35%) 
and the mixture was stirred at room temperature. After 1 h, it was 
made alkaline with 10% aqueous KOH and extracted with diethyl 
ether (3 × 30 mL). After drying (Na2SO4) and solvent evaporation 
crude products 14-18 were purified by column chromatography 
(CHCl3:MeOH 19:1). 
Method B: To a solution of aminodiol 12 (1.8 mmol) in 5 mL 
diethyl ether was added 20 mL aqueous formaldehyde (30%). The 
mixture was stirred at 0 °C for 1 h, then it was made alkaline with 
10% aqueous KOH and extracted with diethyl ether (3 × 30 mL). 
The organic phase was dried (Na2SO4) and the solvent 
evaporated. The crude product was purified by column 
chromatography (CHCl3:MeOH 19:1) to afford 17. 
(1S,5S,5'R,7R)-3'-Benzyl-2-methylspiro[bicyclo[3.2.1]oct[2]ene-
6,5'-oxazolidin]-7-ol (14): Prepared by method A; 0.31 g (60%); 
yellow oil; [α]D20 = -43 (c 0.17, MeOH). 1H NMR (400 MHz, CDCl3) 
 (ppm): 1.66 (d, J = 11.8 Hz, 1H), 1.71 (d, J = 1.4 Hz, 1H), 2.06-
2.11 (m, 1H), 2.21 (br s, 1H), 2.30-2.36 (m, 2H), 2.82 (d, J = 10.9 
Hz, 1H), 3.07 (d, J = 10.9 Hz, 1H), 3.71-3.83 (m, 3H), 4.27 (d, J = 
4.4 Hz, 1H), 4.55 (d, J = 4.4 Hz, 1H), 5.30 (s, 1H), 7.26-7.36 (m, 
5H) . 13C NMR (100 MHz, CDCl3)  (ppm): 24.9 (CH3), 28.9 (CH2), 
29.2 (CH2), 43.4 (CH), 44.1 (CH), 57.3 (CH2), 65.8 (CH2), 82.2 
(CH), 85.2 (Cq), 87.9 (CH2), 119.8 (CH), 127.5 (CH Ar), 128.6 (CH 
Ar), 128.9 (CH Ar), 137.4 (Cq). Anal. Calcd for C18H23NO2: C, 
75.76; H, 8.12; N, 4.91. Found: C, 75.77; H, 8.09; N, 4.95. 
 
(1S,5S,5'R,7R)-2-Methyl-3'-((S)-1-
phenylethyl)spiro[bicyclo[3.2.1]oct[2]ene-6,5'-oxazolidin]-7-ol 
(15): Prepared by method A; 0.38 g (70%); yellow oil; [α]D20 = -51 
(c 0.28, MeOH). 1H NMR (400 MHz, CDCl3)  (ppm): 1.33 (d, J = 
6.5 Hz, 3H), 1.32-1.38 (m, 1H), 1.59 (d, J = 11.8 Hz, 1H), 1.70 (d, 
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J = 1.7 Hz, 3H), 2.05-2.13 (m, 2H), 2.25-2.33 (m, 2H), 2.46 (d, J 
= 9.9 Hz, 1H), 2.81 (br s, 1H), 2.87 (d, J = 9.9 Hz, 1H), 3.42 (q, J 
= 6.5, 13.0 Hz, 1H), 3.75 (d, J = 5.5 Hz, 1H), 4.13 (d, J = 2.9 Hz, 
1H), 4.66 (d, J = 2.9 Hz, 1H), 5.28 (d, J = 1.1 Hz, 1H), 7.24-7.35 
(m, 1H). 13C NMR (100 MHz, CDCl3)  (ppm): 23.3 (CH3), 24.9 
(CH3), 28.8 (CH2), 29.5 (CH2), 43.2 (CH), 44.1 (CH), 61.8 (CH), 
64.2 (CH2), 81.3 (CH), 86.3 (Cq), 86.8 (CH2), 119.7 (CH), 127.2 
(CH Ar), 127.4 (CH Ar), 128.7 (CH Ar), 137.4 (Cq), 144.9 (Cq). 
Anal. Calcd for C19H25NO2: C, 76.22; H, 8.42; N, 4.68. Found: C, 
76.30; H, 8.39; N, 4.70. 
(1S,5S,5'R,7R)-2-Methyl-3'-((R)-1-
phenylethyl)spiro[bicyclo[3.2.1]oct[2]ene-6,5'-oxazolidin]-7-ol 
(16): Prepared by method A; 0.36 g (67%); yellow oil; [α]D20 = -35 
(c 0.26, MeOH). 1H NMR (400 MHz, CDCl3)  (ppm):1.35 (d, J = 
6.5 Hz, 3H), 1.40-1.44 (m, 1H), 1.63 (d, J = 11.8 Hz, 1H), 1.70 (d, 
J = 1.8 Hz, 3H), 2.03-2.10 (m, 1H), 2.19-2.29 (m, 3H), 2.65 (d, J 
= 10 Hz, 1H), 2.79 (d, J = 9.0 Hz, 1H), 3.03 (d, J = 9.9 Hz, 1H), 
3.46 (q, J = 6.4, 12.8 Hz, 1H), 3.80 (q, J = 5.7, 8.8 Hz, 1H), 4.12 
(d, J = 3.4 Hz, 1H), 4.40 (d, J = 3.5 Hz, 1H), 5.26 (s, 1H), 7.24-
7.34 (m, 5H). 13C NMR (100 MHz, CDCl3)  (ppm): 23.8 (CH3), 
24.9 (CH3), 29.0 (CH2), 29.3 (CH2), 43.0 (CH), 44.2 (CH), 61.4 
(CH), 64.2 (CH2), 81.9 (CH), 86.1 (Cq), 86.7 (CH2), 119.7 (CH), 
127.2 (CH Ar), 127.4 (CH Ar), 128.7 (CH Ar), 137.5 (Cq), 144.9 
(Cq Ar). Anal. Calcd for C19H25NO2: C, 76.22; H, 8.42; N, 4.68. 
Found: C, 76.25; H, 8.45; N, 4.65. 
(1S,5S,5'R,7R)-3'-Isopropyl-2-
methylspiro[bicyclo[3.2.1]oct[2]ene-6,5'-oxazolidin]-7-ol (17): 
Prepared by method B; 0.34 g (70%); yellow oil; [α]D20 = -47 (c, 
0.15 MeOH). 1H NMR (500 MHz, CDCl3)  (ppm): 1.08 (dd, J = 
7.6, 12.6 Hz, 6H), 1.42-1.48 (m, 1H), 1.66 (d, J = 14.7 Hz, 1H), 
1.71 (d, J = 1.8 Hz, 3H), 2.02-2.09 (m, 1H), 2.17-2.32 (m, 3H), 
2.45-2.52 (m, 1H), 2.51 (d, J = 11.9 Hz, 1H), 2.79 (d, J = 10.0 Hz, 
1H), 3.10 (d, J = 11.7 Hz, 1H), 3.82 (dd, J = 7.4, 9.9 Hz, 1H), 4.06 
(d, J = 3.3 Hz, 1H), 4.65 (d, J = 3.4 Hz, 1H), 5.28 (s, 1H). 13C NMR 
(125 MHz, CDCl3)  (ppm): 21.8 (CH3), 22.0 (CH3), 24.8 (CH3), 
28.8 (CH2), 29.4 (CH2), 43.0 (CH), 43.9 (CH), 52.2 (CH), 63.7 
(CH2), 81.5 (CH), 86.5 (Cq), 86.7 (CH2), 119.7 (CH), 137.2 (CH2). 
Anal. Calcd for C14H23NO2: C, 70.85; H, 9.77; N, 5.90. Found: C, 
70.80; H, 9.75; N, 5.89. 
(1S,5S,5'R,7R)-3'-Isopropyl-2-
methylspiro[bicyclo[3.2.1]oct[2]ene-6,5'-oxazolidin]-7-ol (17) and 
(4aR,5S,9S,9aR)-3-isopropyl-8-methyl-2,3,4,4a,5,6,9,9a-
octahydro-5,9-methanocyclohepta[e][1,3]oxazin-4a-ol (18): 
Prepared by method A; 0.36 g (74%, 17:18 = 2:1); yellow oil. 1H 
NMR (500 MHz, DMSO-d6)  (ppm): 1.24-1.28 (m, 6H, minor 
overlapped with major), 1.63 (s, 3H, minor overlapped with major), 
1.50-1.58 (m, 2H, minor overlapped with major), 1.99-2.26 (m, 2H, 
minor overlapped with major), 2.18 (s, 1H, minor), 2.38 (s, 1H, 
major), 2.80-2.93 (m, 2H, minor), 3.27-3.30 (m, 1H, minor), 3.30 
(m, 1H, major), 3.19-3.70 (m, 2H, major), 3.85 (d, J = 5.1 Hz, 1H, 
minor), 3.94 (br s, 1H, major), 4.59-4.71 (m, 2H, minor overlapped 
with major), 5.01 (s, 1H, major), 5.07 (s, 1H, minor), 5.14 (s, 1H, 
minor overlapped with major), 13C NMR (125 MHz, DMSO-d6)  
(ppm): 18.3 (CH3, minor), 18.5 (CH3, major), 24.7 (CH3, major), 
24.9 (CH3, minor), 27.9 (CH2, minor), 28.0 (CH2, minor), 28.2 (CH2, 
major), 28.3 (CH2, major), 41.5 (CH, minor), 43.4 (CH, major), 
50.5 (CH, minor), 52.3 (CH2, minor), 55.2 (CH, major), 59.2 (CH2, 
major), 74.7 (Cq, minor), 77.1 (CH, minor), 80.9 (CH, major), 80.9 
(CH2, minor), 82.7 (CH2, major), 87.4 (Cq, major), 118.8 (CH, 
minor), 118.9 (CH, major), 136.7 (Cq, minor), 137.3 (Cq, major). 
Anal. Calcd for C14H23NO2: C, 70.85; H, 9.77; N, 5.90. Found: C, 
70.80; H, 9.75; N, 5.89. 
General procedure for the preparation of aminodiol 13: To a 
suspension of palladium-on-carbon (5% Pd, 0.22 g) in MeOH (50 
mL) was added aminodiols 9-11 (14.0 mmol) in MeOH (100 mL), 
and the mixture was stirred under a H2 atmosphere (1 atm) at 
room temperature. When the reaction was completed (as 
monitored by TLC, 20 h), the mixture was filtered through a Celite 
pad and the solution was evaporated to dryness. The crude 
product was crystallized in diethyl ether, resulting in 13 as white 
crystals. 
(1S,5S,6R,7R)-6-(Aminomethyl)-2-methylbicyclo[3.2.1]oct-2-
ene-6,7-diol (13): 1.80 g (70%); white crystals; mp: 197-210 °C; 
[α]D20 = -51 (c 0.20 MeOH). 1H NMR (500 MHz, DMSO-d6)  
(ppm): 1.48 (d, J = 11.7 Hz, 1H), 1.52-1.56 (m, 1H), 1.62 (s, 3H), 
2.00 (d, J = 17.2 Hz, 1H), 2.15 (br s, 1H), 2.20-2.23 (m, 2H), 2.70 
(d, J = 12.7 Hz, 1H), 2.80 (d, J = 12.7 Hz, 1H), 3.79 (t, J = 5.6 Hz, 
1H), 3.97 (s, 1H), 5.14 (s, 1H), 5.53 (d, J = 5.7 Hz, 1H), 7.80 (br 
s, 3H). 13C NMR (125 MHz, DMSO-d6)  (ppm): 24.8 (CH3), 27.8 
(CH2), 28.2 (CH2), 43.4 (CH), 47.4 (CH2), 74.7 (Cq), 77.0 (CH), 
118.9 (CH), 137.2 (Cq). Anal. Calcd for C10H17NO2: C, 65.54; H, 
9.35; N, 7.64. Found: C, 65.55; H, 9.37; N, 7.62. 
General procedure for the reaction of benzaldehyde with 
diethylzinc in the presence of chiral catalysts: To the 
respective catalyst (0.1 mmol), 1 M Et2Zn in n-hexane solution (3 
mL, 3 mmol) was added under an argon atmosphere at room 
temperature. The solution was stirred for 25 min at room 
temperature then benzaldehyde (1 mmol) was added. After 
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stirring at room temperature for a further 20 h, the reaction was 
quenched with saturated NH4Cl solution (15 mL) and the mixture 
was extracted with EtOAc (2 × 20 mL). The combined organic 
phase was washed with H2O (10 mL), dried (Na2SO4) and 
evaporated under vacuum. The crude secondary alcohols 
obtained were purified by flash column chromatography (n-
hexane/EtOAc = 4/1). The ee and absolute configuration of the 
resulting material were determined by chiral GC on CHIRASIL-
DEX CB column after O-acetylation in a AcO2/DMPA/pyridine 
system. 
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Starting from natural (-)-limonene, a 
limonene-based aminodiol library was 
created whereas the reaction of 
aminodiols with formaldehyde resulted 
in limonene-fused spirooxazolidines in 
N-substituent dependent regio-
selective ring closures. The aminodiol 
derivatives were applied as chiral 
catalysts in the addition of diethylzinc 
to benzaldehyde. The N-substituent-
dependent ring closure was explained 
by comparative DFT modelling. 
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